Pasithea Therapeutics (KTTA) Assets Average (2021 - 2024)
Historic Assets Average for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $18.2 million.
- Pasithea Therapeutics' Assets Average fell 4724.24% to $18.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $18.2 million, marking a year-over-year decrease of 4724.24%. This contributed to the annual value of $35.6 million for FY2023, which is 2761.78% down from last year.
- Per Pasithea Therapeutics' latest filing, its Assets Average stood at $18.2 million for Q3 2024, which was down 4724.24% from $20.0 million recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Assets Average ranged from a high of $52.2 million in Q1 2022 and a low of $18.2 million during Q3 2024
- In the last 4 years, Pasithea Therapeutics' Assets Average had a median value of $38.6 million in 2021 and averaged $37.4 million.
- As far as peak fluctuations go, Pasithea Therapeutics' Assets Average skyrocketed by 2746.72% in 2022, and later tumbled by 5003.2% in 2024.
- Pasithea Therapeutics' Assets Average (Quarter) stood at $37.2 million in 2021, then rose by 27.47% to $47.4 million in 2022, then plummeted by 40.1% to $28.4 million in 2023, then tumbled by 36.06% to $18.2 million in 2024.
- Its last three reported values are $18.2 million in Q3 2024, $20.0 million for Q2 2024, and $24.3 million during Q1 2024.